Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Blood (2023) 142 (1): 73–89.

https://doi.org/10.1182/blood.2022016896

Published: 2023

Includes: Supplemental data

Journal Articles

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Erik Boberg, Lena Von Bahr, MD PhD, Nina Heldring, PhD, Gabriel Afram, MD, Ellen Iacobaeus, MD PhD, Carina Lindström, RN, Karin Garming-Legert, DMD, PhD, Per Ljungman, Rachael Sugars, PhD, Lindsay Davies, MD PhD, Nadir Kadri, PhD, Katarina Le Blanc, MD PhD

Blood (2017) 130 (Supplement 1): 3253.

https://doi.org/10.1182/blood.V130.Suppl_1.3253.3253

Published: 2017

Journal Articles

Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation

Blood (2016) 128 (22): 3374.

https://doi.org/10.1182/blood.V128.22.3374.3374

Published: 2016

Journal Articles

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Christian Scharenberg, MD, Petter S. Woll, PhD, Valentina Giai, MD PhD, Andrea Pellagatti, PhD, Leonie Saft, MD PhD, Marios Dimitriou, Martin Jädersten, Monika Jansson, Iyadh Douagi, PhD, Donna S. Neuberg, ScD, Mohsen Karimi, Katarina Le Blanc, MD, PhD, Jacqueline Boultwood, PhD, Sten Eirik Jacobsen, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2016) 128 (22): 4329.

https://doi.org/10.1182/blood.V128.22.4329.4329

Published: 2016

Journal Articles

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Lena Von Bahr, MD, Lindsay Davies, PhD, Gabriel Afram, MD, Carina Modin, Karin Garming-Legert, PhD, Hans Hägglund, MD PhD, Per T. Ljungman, MD PhD, Katarina Le Blanc, MD, PhD

Blood (2015) 126 (23): 3138.

https://doi.org/10.1182/blood.V126.23.3138.3138

Published: 2015

Journal Articles

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Monika Dolinska, Johannis Klang, Pingnan Xiao, MD, Andranik Durgaryan, Lakshmi Sandhow, Anne-Sofie Johansson, Makoto Kondo, Stefan Deneberg, MD, PhD, Johanna Ungerstedt, Associate Professor, Katarina Le Blanc, MD, PhD, Leif Stenke, MD PhD, Marja Ekblom, Ulla Stromberg, MDPhD, Satu Mustjoki, MD PhD, Soren Lehmann, MD PhD, Hong Qian, PhD

Blood (2015) 126 (23): 2398.

https://doi.org/10.1182/blood.V126.23.2398.2398

Published: 2015

Journal Articles

Stromal cell–mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling

Regina Jitschin, Martina Braun, Mirjeta Qorraj, Domenica Saul, Katarina Le Blanc, Thorsten Zenz, Dimitrios Mougiakakos

Blood (2015) 125 (22): 3432–3436.

https://doi.org/10.1182/blood-2014-10-607036

Published: 2015

Includes: Supplemental data

Journal Articles

CLL-cells induce IDO hi CD14 + HLA-DR lo myeloid-derived suppressor cells that inhibit T-cell responses and promote T Regs

Regina Jitschin, Martina Braun, Maike Büttner, Katja Dettmer-Wilde, Juliane Bricks, Jana Berger, Michael J. Eckart, Stefan W. Krause, Peter J. Oefner, Katarina Le Blanc, Andreas Mackensen, Dimitrios Mougiakakos

Blood (2014) 124 (5): 750–760.

https://doi.org/10.1182/blood-2013-12-546416

Published: 2014

Includes: Supplemental data

Journal Articles

The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

Dimitrios Mougiakakos, Regina Jitschin, C. Christian Johansson, Riki Okita, Rolf Kiessling, Katarina Le Blanc

Blood (2011) 117 (18): 4826–4835.

https://doi.org/10.1182/blood-2010-12-324038

Published: 2011

Journal Articles

Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune-Modulatory Function. Implications for off-the Shelf ES-MSC Therapies.

Ou Li, PhD, Ariane Tormin, PhD, Jan Claas Brune, MS, Berit Sundberg, Johan Hyllner, PhD, Katarina Le Blanc, MD, PhD, Stefan Scheding, MD

Blood (2010) 116 (21): 3858.

https://doi.org/10.1182/blood.V116.21.3858.3858

Published: 2010

Journal Articles

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Lynne Margaret Ball, MD, PhD, Maria E. Bernardo, MD, PhD, Jaap Jan Zwaginga, MD, PhD, Maarten van Tol, PhD, Angela Cometa, Helene Roelofs, PhD, Giovanna Giorgiani, Cornelia M Jol-van der Zijde, PhD, Maria Antonietta Avanzini, MD, Katarina Le Blanc, MD, PhD, Alice Bertaina, Francesco Frassoni, MD, Willem E. Fibbe, MD, PhD, Olle Ringden, MD, R. Maarten Egeler, MD, PhD, Franco Locatelli, MD, Arjan Lankester, MD, PhD

Blood (2010) 116 (21): 2336.

https://doi.org/10.1182/blood.V116.21.2336.2336

Published: 2010

Journal Articles

Human Mesenchymal Stem Cells Elicit Complement Activation in Human Blood.

Katarina Le Blanc, MD, PhD, Guido Moll, Ida Rasmusson, Kristina Nilsson Ekdahl, Graciela Elgue, Berit Sundberg, Bo Nilsson

Blood (2009) 114 (22): 4580.

https://doi.org/10.1182/blood.V114.22.4580.4580

Published: 2009

Journal Articles

HLA Mismatched MSC Suppress T Lymphocyte Allo responses in Vitro and Do Not Induce Immunological Memory in Recipients of MSC Infusion

Mikael Sundin, M.D., A. John Barrett, M.D., FRCP, Olle Ringdén, M.D., Ph.D., Mehmet Uzunel, Ph.D., Helena Lönnies, Åsa-Lena Dackland, Birger Christensson, M.D., Ph.D., Katarina Le Blanc, M.D., Ph.D.

Blood (2008) 112 (11): 4740.

https://doi.org/10.1182/blood.V112.11.4740.4740

Published: 2008

Journal Articles

Persistence of Human Parvovirus B19 in Multipotent Mesenchymal Stromal Cells Expressing the Erythrocyte P antigen: Implications for Transplantation

Mikael Sundin, M.D., Anna Lindblom, M.D., Claes Örvell, M.D., Ph.D., A. John Barrett, M.D., FRCP, Berit Sundberg, Emma Watz, M.D., Agneta Wikman, M.D., Ph.D., Kristina Broliden, M.D., Ph.D., Katarina Le Blanc, M.D., Ph.D.

Blood (2008) 112 (11): 4745.

https://doi.org/10.1182/blood.V112.11.4745.4745

Published: 2008

Journal Articles

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Helen Karlsson, Sujith Samarasinghe, Lynne M. Ball, Berit Sundberg, Arjan C. Lankester, Francesco Dazzi, Mehmet Uzunel, Kanchan Rao, Paul Veys, Katarina Le Blanc, Olle Ringdén, Persis J. Amrolia

Blood (2008) 112 (3): 532–541.

https://doi.org/10.1182/blood-2007-10-119370

Published: 2008

Journal Articles

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Hamdy Omar, MD, Hans Hägglund, MD, PhD, Åsa Gustafsson-Jernberg, MD, PhD, Katarina Le Blanc, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD, Olle Ringdén, MD, PhD, Elda Sparrelid, MD, PhD, Mikael Sundin, Jacek H. Winiarski, MD, PhD, Zhibing Yun, PhD, Per T. Ljungman, MD, PhD

Blood (2007) 110 (11): 2969.

https://doi.org/10.1182/blood.V110.11.2969.2969

Published: 2007

Journal Articles

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Katarina Le Blanc, MD, PhD, Francesco Frassoni, MD, PhD, Lynne Ball, MD, PhD, Edoardo Lanino, MD, PhD, Berit Sundberg, B.Sc, Lena Lonnies, B.Sc, Helene Roelofs, PhD, Giorgio Dini, MD, PhD, Andrea Bacigalupo, MD, PhD, Franco Locatelli, MD, PhD, Willem F. Fibbe, MD, PhD, Olle Ringden, MD, PhD

Blood (2006) 108 (11): 5304.

https://doi.org/10.1182/blood.V108.11.5304.5304

Published: 2006

Journal Articles

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Katarina Le Blanc, MD, PhD, Francesco Frassoni, MD,PhD, Lynne Ball, MD, PhD, Edoardo Lanino, MD, PhD, Berit Sundberg, B.Sc, Helena Lonnies, B.Sc, Helene Roelofs, PhD, Giorgio Dini, MD, PhD, Andrea Bacigalupo, MD, PhD, Franco Locatelli, MD, PhD, Willem F. Fibbe, MD, PhD, Olle Ringden, MD, PhD

Blood (2006) 108 (11): 2918.

https://doi.org/10.1182/blood.V108.11.2918.2918

Published: 2006

Journal Articles

Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.

Lynne Margaret van Velzen-Ball, MD, PhD, Katarina Le Blanc, MD, PhD, Arjen C. Lankester, MD, PhD, Helene Roelofs, PhD, Maarten Egeler, MD, PhD, Francesco Frassoni, MD, PhD, Olle Ringdén, MD, PhD, Willem E. Fibbe, MD, PhD

Blood (2005) 106 (11): 2911.

https://doi.org/10.1182/blood.V106.11.2911.2911

Published: 2005

Journal Articles

Mesenchymal Stem Cells for Treatment of Severe Acute and Extensive Chronic Graft-Versus-Host Disease.

Katarina Le Blanc, MD, PhD, Francesco Frassoni, MD, Lynne Ball, MD, Mehmet Uzunel, PhD, Edoardo Lanini, MD, Berit Sundberg, Helena Lonnies, Giorgio Dini, MD, Andrea Bacigalupo, MD, Franco Locatelli, MD, Willem E. Fibbe, MD, Olle T.H. Ringden, MD, PhD

Blood (2005) 106 (11): 143.

https://doi.org/10.1182/blood.V106.11.143.143

Published: 2005

NARROW

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Stromal cell–mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling

CLL-cells induce IDO hi CD14 + HLA-DR lo myeloid-derived suppressor cells that inhibit T-cell responses and promote T Regs

The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune-Modulatory Function. Implications for off-the Shelf ES-MSC Therapies.

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Human Mesenchymal Stem Cells Elicit Complement Activation in Human Blood.

HLA Mismatched MSC Suppress T Lymphocyte Allo responses in Vitro and Do Not Induce Immunological Memory in Recipients of MSC Infusion

Persistence of Human Parvovirus B19 in Multipotent Mesenchymal Stromal Cells Expressing the Erythrocyte P antigen: Implications for Transplantation

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.

Mesenchymal Stem Cells for Treatment of Severe Acute and Extensive Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only